JB Pharma Reduces The Price of Critical Heart Failure Medicine AZMARDA Nearly By 50%

Chandigarh : JB Chemicals & Pharmaceuticals Ltd (JB Pharma) announced a substantial price decrease of approximately 50% for the critical heart failure drug "Azmarda". Azmarda, which contains the patented molecule Saccubutril-Valsartan is indicated for Heart failure which ails 8 to 12 million people in the country. After the price reduction, Azmarda (Saccubutril-Valsartan), 50 mg will be available at INR 39.6 per tablet as compared to INR 78 per tablet. 35.7% of the Punjab population is hypertensive, which is one of the important risk factors for heart failure. The price reduction will make the management of heart failure more affordable and accessible for people from all strata of society.

Commenting on the move, Dilip Singh Rathore, President - Domestic Business, JB Pharma, said, "Being a leading player in the cardiac segment, JB has decided to take the lead in making their Azmarda drug more accessible and affordable for heart failure patients in India. This is in line with our strategy of providing innovative and quality treatment to a larger patient pool at the most affordable price points. With this move, the overall monthly treatment cost will reduce significantly from INR 4500 to INR 2200. The HF drug also helps in reducing hospitalization cost by around INR 1,00,000 at the minimum. The drug with reduced MRP is available to consumers from December 2022."

While speaking on different aspects of Heart failure during the conference, Dr Rajat Sharma, Consultant Cardiologist, Cardiac Electrophysiologist at Fortis Hospital, Mohali said, "India is more prone to cardiac ailments like Heart failure for being the populous country, and 1 % of the Indian population suffers from Heart failure. Younger Indians die of heart failure 5 times more than that global mortality. It seems that something is amiss in India either we are unable to provide proper treatment or there is a lack of awareness amongst the masses. It is worrisome, and we need to spread more and more awareness about this condition to the people. 

Throwing light on the heart failure conditions during the conference, Dr. U P Singh, Consultant Cardiologist, Prime Diagnostic Centre & Heart Institute, Chandigarh, said, "First, we need to understand what Heart failure is. Heart failure doesn't mean it is the end of life, but it means that the heart is not pumping adequate blood to the body.